Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms

Modern Pathology

Volumn 21, Issue 8, 2008, Pages 943-949

  Weaver, Joshua ^a   Downs Kelly, Erinn ^a   Goldblum, John R ^a,c   Turner, Sondra ^a   Kulkarni, Sucheta ^a   Tubbs, Raymond R ^a   Rubin, Brian P ^a   Skacel, Marek ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Dahl Chase Pathology Associates   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Atypical lipomatous tumor; Dedifferentiated liposarcoma; FISH; MDM2; Well differentiated liposarcoma

Indexed keywords

PROTEIN MDM2;

ANGIOLIPOMA; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CHROMOSOME 12; CHROMOSOME 12Q; CHROMOSOME 15; CYTOLOGY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; LIPOSARCOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SPINDLE CELL; STATISTICAL SIGNIFICANCE; TISSUE MICROARRAY; TUMOR BIOPSY;

ANEUPLOIDY; CHROMOSOMES, HUMAN, PAIR 12; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIPOMA; LIPOSARCOMA; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PROTO-ONCOGENE PROTEINS C-MDM2; SOFT TISSUE NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 48749110337     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2008.84     Document Type: Article

References (24)

1. Nascimento AG. Dedifferentiated liposarcoma. Semin Diagn Pathol 2001;18:263-266.
2. Laurino L, Furlanetto A, Orvieto E, et al. Well-differentiated liposarcoma (atypical lipomatous tumors). Semin Diagn Pathol 2001;18:258-262.
3. Weiss SW, Goldblum JR. Liposarcoma. Enzinger and Weiss's Soft Tissue Tumors, Vol., 5th edn. Mosby: St Louis, 2008, pp 477-516.
4. Enzinger FM, Winslow DJ. Liposarcoma. A study of 103 cases. Virchows Arch Pathol Anat Physiol Klin Med 1962;335:367-388.
5. Evans HL. Liposarcoma: a study of 55 cases with a reassessment of its classification. Am J Surg Pathol 1979;3:507-523.
6. Karakousis CP, Dal Cin P, Turc-Carel C, et al. Chromosomal changes in soft tissue sarcomas. A new diagnostic parameter. Arch Surg 1987;122:1257-1260.
7. Pedeutour F, Suijkerbuijk RF, Van Gaal J, et al. Chromosome 12 origin in rings and giant markers in well-differentiated liposarcoma. Cancer Genet Cytogenet 1993;66:133-134.
8. Dal Cin P, Kools P, Sciot R, et al. Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. Cancer Genet Cytogenet 1993;68:85-90.
9. Pedeutour F, Suijkerbuijk RF, Forus A, et al. Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma. Genes Chromosomes Cancer 1994;10:85-94.
10. Pedeutour F, Forus A, Coindre JM, et al. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 1999;24:30-41.
11. Vargas DA, Takahashi S, Ronai Z. Mdm2: A regulator of cell growth and death. Adv Cancer Res 2003;89:1-34.
12. Skacel M, Skilton B, Pettay JD, et al. Tissue microarrays: a powerful tool for high-throughput analysis of clinical specimens: a review of the method with validation data. Appl Immunohistochem Mol Morphol 2002;10:1-6.
13. Patel RM, Downs-Kelly E, Weiss SW, et al. Dual-color, break-apart fluorescence in situ hybridization for EWS gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma. Mod Pathol 2005;18:1585-1590.
14. Binh MB, Sastre-Garau X, Guillou L, et al. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol 2005;29:1340-1347.
15. Binh MB, Garau XS, Guillou L, et al. Reproducibility of MDM2 and CDK4 staining in soft tissue tumors. Am J Clin Pathol 2006;125:693-697.
16. Shimada S, Ishizawa T, Ishizawa K, et al. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers. Hum Pathol 2006;37:1123-1129.
17. Forus A, Bjerkehagen B, Sirvent N, et al. A well-differentiated liposarcoma with a new type of chromosome 12-derived markers. Cancer Genet Cytogenet 2001;131:13-18.
18. Micci F, Teixeira MR, Bjerkehagen B, et al. Characterization of supernumerary rings and giant marker chromosomes in well-differentiated lipomatous tumors by a combination of G-banding, CGH, M-FISH, and chromosome- and locus-specific FISH. Cytogenet Genome Res 2002;97:13-19.
19. Pilotti S, Della Torre G, Mezzelani A, et al. The expression of MDM2/CDK4 gene product in the differential diagnosis of well-differentiated liposarcoma and large deep-seated lipoma. Br J Cancer 2000;82:1271-1275.
20. Jacob EK, Erickson-Johnson M, Wang X, et al. Assessment of MDM2 amplification using fluorescence in situ hybridization on paraffin embedded tissues discriminates atypical lipomatous tumors from lipomas. Mod Pathol 2006;19:13A.
21. Antonescu CR, Tschernyavsky SJ, Decuseara R, et al. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res 2001;7:3977-3987.
22. Fletcher CDM, van den Berg E, Molenaar WM. Pleomorphic malignant fibrous histiocytoma/Undifferentiated high grade pleomorphic sarcoma In: Fletcher CDM, Krishnan Unni K, Mertens F (eds). World Health Organization Classification of Tumours Pathology and Genetics Tumours of Soft Tissue and Bone, Vol. IARC Press: Lyon, 2002, pp 120-122.
23. Coindre JM, Hostein I, Maire G, et al. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity. J Pathol 2004;203:822-830.
24. Coindre JM, Mariani O, Chibon F, et al. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma. Mod Pathol 2003;16:256-262.